Stay updated on Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Sign up to get notified when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.

Latest updates to the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision note updated to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows Revision: v3.4.2 replacing v3.4.1, indicating a minor maintenance update that does not alter study information.SummaryDifference0.1%

- Check40 days agoChange DetectedThe revision label on the page was updated from v3.4.0 to v3.4.1, with no changes to the study details or other substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now includes a glossary toggle, a 'Last Update Submitted that Met QC Criteria' line, a 'No FEAR Act Data' notice, and Revision: v3.4.0. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a minor UI/documentation update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a centralized Locations section listing study sites by state (California, Michigan, New Jersey, Ohio, Washington) and removed the separate state location subsections.SummaryDifference0.6%

Stay in the know with updates to Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Retroviral Vector and Prodrug for Brain Tumor Surgery Clinical Trial page.